» Articles » PMID: 17257897

Natural Regulatory T Cells: Mechanisms of Suppression

Overview
Journal Trends Mol Med
Date 2007 Jan 30
PMID 17257897
Citations 276
Authors
Affiliations
Soon will be listed here.
Abstract

Natural FOXP3+CD25+CD4+ regulatory T cells (Tregs) actively suppress pathological and physiological immune responses, contributing to the maintenance of immunological self-tolerance and immune homeostasis. Various molecular and cellular events have been described to explain the mechanism(s) of Treg-mediated suppression. However, none of the proposed mechanisms can explain all aspects of suppression. It is probable that various combinations of several mechanisms are operating, depending on the milieu and the type of immune responses, although there might be a single key mechanism that has a predominant role. Further studies of suppression and search for Treg-specific cell surface molecules are required for potential clinical application to treat and prevent immunological diseases and to control immune responses for the benefit of the host.

Citing Articles

Adipose-derived mesenchymal stem cells combined with platelet-rich plasma are superior options for the treatment of osteoarthritis.

He W, Zhao J, Liu J, Wang F, Xu Z J Orthop Surg Res. 2025; 20(1):2.

PMID: 39748384 PMC: 11697913. DOI: 10.1186/s13018-024-05396-2.


Immunomodulatory and anti-inflammatory properties of immunoglobulin G antibodies.

Hematianlarki M, Nimmerjahn F Immunol Rev. 2024; 328(1):372-386.

PMID: 39340138 PMC: 11659946. DOI: 10.1111/imr.13404.


MEK-inhibitor treatment reduces the induction of regulatory T cells in mice after influenza A virus infection.

Koch-Heier J, Vogel A, Full Y, Ebensperger M, Schonsiegel A, Zinser R Front Immunol. 2024; 15:1360698.

PMID: 38979428 PMC: 11228811. DOI: 10.3389/fimmu.2024.1360698.


The association between immune cells and breast cancer: insights from Mendelian randomization and meta-analysis.

Xu W, Zhang T, Zhu Z, Yang Y Int J Surg. 2024; 111(1):230-241.

PMID: 38935111 PMC: 11745723. DOI: 10.1097/JS9.0000000000001840.


SIRPG promotes lung squamous cell carcinoma pathogenesis via M1 macrophages: a multi-omics study integrating data and Mendelian randomization.

Mao G, Li J, Wang N, Yu H, Han S, Xiang M Front Oncol. 2024; 14:1392417.

PMID: 38894865 PMC: 11183323. DOI: 10.3389/fonc.2024.1392417.